Bone Biologics Co. (NASDAQ:BBLG) was the recipient of a large growth in short interest in July. As of July 15th, there was short interest totalling 5,300 shares, a growth of 562.5% from the June 30th total of 800 shares. Based on an average trading volume of 835,900 shares, the short-interest ratio is presently 0.0 days. Currently, 1.0% of the shares of the stock are short sold.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.